8-K/A

AMENDED CURRENT REPORT

Company: Edesa Biotech, Inc.
Filed: August 14, 2019
Period of Report: June 7, 2019
Accession Number: 0001654954-19-009573

View Document ↗ View on SEC.gov ↗